1. Home
  2. PRPL vs RGNT Comparison

PRPL vs RGNT Comparison

Compare PRPL & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Innovation Inc.

PRPL

Purple Innovation Inc.

SELL

Current Price

$2.27

Market Cap

13.9M

ML Signal

SELL

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$1.55

Market Cap

14.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRPL
RGNT
Founded
2010
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
14.3M
IPO Year
2015
2022

Fundamental Metrics

Financial Performance
Metric
PRPL
RGNT
Price
$2.27
$1.55
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $20.63
N/A
AVG Volume (30 Days)
44.1K
★ 46.7K
Earning Date
11-03-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 152.75
N/A
EPS
N/A
★ N/A
Revenue
★ $468,725,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.50
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.28
$1.23
52 Week High
$10.00
$15.50

Technical Indicators

Market Signals
Indicator
PRPL
RGNT
Relative Strength Index (RSI) 40.77 34.37
Support Level $0.36 $1.23
Resistance Level $10.00 $2.48
Average True Range (ATR) 0.16 0.11
MACD 0.09 -0.02
Stochastic Oscillator 58.49 16.98

Price Performance

Historical Comparison
PRPL
RGNT

About PRPL Purple Innovation Inc.

Purple Innovation Inc designs and manufactures sleep products. Using its GelFlex Grid technology, the company designs, manufactures, and offers branded comfort sleep products, including mattresses, pillows, cushions, mattress protectors, bases, sheets, and others. It markets and sells these products through direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: